On the other hand, as a modulator of activity of STAT5, a protein inhibitor of activated STAT3 (PIAS3), which regulates different DNA binding transcription factors implicated in the immune response (e.g., NFκB, SMAD, and MITF), was recognized in breast cancer [19]. This evidence concerns the gene STAT5B and breast carcinoma.